REGULATION AND DIFFERENTIAL EXPRESSION OF NEUTRAL ENDOPEPTIDASE-24.11 IN HUMAN ENDOTHELIAL-CELLS

Neutral endopeptidase 24.11, a membrane-bound metallopeptidase, cleaves and degrades vasoactive peptides such as atrial natriuretic peptide, endothelin, angiotensin I, substance P, and bradykinin. Therefore, the presence of this metallopeptidase may contribute to the regulation of vascular tone and local inflammatory responses in the vascular endothelium and elsewhere. We determined neutral endopeptidase in cultured human endothelial cells from different vascular beds and studied its regulation by protein kinase C. Neutral endopeptidase was detected in air cultured endothelial cell types. Lowest concentrations were measured in human endothelial cells from umbilical veins (360+/-14 pg/mg protein), followed by pulmonary and coronary arteries; higher concentrations were found in endothelial cells from the cardiac microcirculation (1099+/-73 pg/mg protein). Neutral endopeptidase content increased during cell growth but was not affected by endothelial cell growth factor or modifications of the growth medium. Stimulation of protein kinase C with 1-oleoyl-2 acetyl-rac-glycerol (0.1 to 1 mu mol/L) and phorbol 12-myristate 13-acetate (0.01 to 0.1 mu mol/L) induced a time- and concentration-dependent increase of endothelial cells that was inhibited by cycloheximide (5 mu mol/L), an inhibitor of protein synthesis. Incubation with phospholipase C (1 mu mol/L) and thrombin (10 IU/mL) induced upregulation of neutral endopeptidase, resulting in 158+/-26% and 150+/-22% increases, respectively, compared with controls. The thrombin effect was inhibited by calphostin C (1 mu mol/L), an inhibitor of protein kinase C. Endothelial neutral endopeptidase is constitutively expressed in endothelial cells from different origins and is inducible by thrombin via activation of the protein kinase C pathway.